CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...